Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Bone Cancer Research Trust (BCRT) is the leading charity dedicated to fighting primary bone cancer through research, awareness, and support. Based in the United Kingdom, the organization funds a wide range of pioneering research projects aimed at improving outcomes for patients with osteosarcoma, Ewing sarcoma, chondrosarcoma, and other rare bone cancers. BCRT also provides vital information and support services to patients and their families while advocating for earlier diagnosis and better treatment options. By collaborating with academic institutions and healthcare professionals, the Trust plays a central role in the global effort to understand and treat primary bone malignancies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bone Cancer Research Trust.